Speech Intelligibility clinical trials

Explore recruiting speech intelligibility clinical trials.

Recruiting speech intelligibility studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Speech Intelligibility trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Extracellular Vesicle-enriched Secretome Fraction (VSF1.01) for the Reduction of Cochlear Implant Surgery Related Trauma (ESCRT). An open-label monocentric phase I/IIa pilot study to investigate the safety of intracochlear application of VSF1.01 enriched with hUC-MSC-EVs in patients receiving cochlear implantation.

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Speech Intelligibility trials by city

Speech Intelligibility in Toronto Speech Intelligibility in Vancouver Speech Intelligibility in Montreal Speech Intelligibility in Calgary Speech Intelligibility in Edmonton Speech Intelligibility in Ottawa Speech Intelligibility in Winnipeg Speech Intelligibility in Quebec City Speech Intelligibility in Hamilton Speech Intelligibility in Kitchener Speech Intelligibility in London Speech Intelligibility in Halifax Speech Intelligibility in New York Speech Intelligibility in Los Angeles Speech Intelligibility in Chicago Speech Intelligibility in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease